Ferrosa Therapeutics
PrivateLast Round
Seed
Apr 23, 2026
Total Funding Raised
$3.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ferrosa Therapeutics operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was a Seed round in April 2026.
Ferrosa Therapeutics is a biotechnology company developing a first-in-class bispecific antibody to treat anemia of inflammation across chronic kidney disease, autoimmune disease, and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ferrosa Therapeutics Comparables
Compare Ferrosa Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Disc Medicine | 75% | |
| Dexoligo Therapeutics | 71% | |
| Keros Therapeutics | 71% |
For institutional investors. Book with your work email.
Ferrosa Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Ferrosa Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forty51 Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
$4M round led by Forty51 Ventures
For institutional investors. Book with your work email.
Ferrosa Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ferrosa Therapeutics's valuation, stock price, and market status.
Is Ferrosa Therapeutics a public or private company?
Ferrosa Therapeutics is a private company.
What is the current stock price of Ferrosa Therapeutics?
Ferrosa Therapeutics is a private company, so its shares have no public market price. Caplight tracks Ferrosa Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ferrosa Therapeutics worth (valuation)?
Valuation information for Ferrosa Therapeutics is not publicly available.
Can I buy Ferrosa Therapeutics stock?
Ferrosa Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ferrosa Therapeutics's last funding round?
Ferrosa Therapeutics's most recent funding round was Seed on April 23, 2026.
Who are the main investors in Ferrosa Therapeutics?
Key investors in Ferrosa Therapeutics include Forty51 Ventures.
Will Ferrosa Therapeutics IPO soon?
No public IPO plans have been announced for Ferrosa Therapeutics.
How can I track Ferrosa Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Ferrosa Therapeutics's shares on secondary markets.